These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 18639498

  • 1. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.
    Saifee S, Joelson D, Braude J, Shrestha R, Johnson M, Sellers M, Galambos MR, Rubin RA.
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1167-9. PubMed ID: 18639498
    [Abstract] [Full Text] [Related]

  • 2. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
    Kovari H, Ledergerber B, Peter U, Flepp M, Jost J, Schmid P, Calmy A, Mueller NJ, Muellhaupt B, Weber R, Swiss HIV Cohort Study.
    Clin Infect Dis; 2009 Aug 15; 49(4):626-35. PubMed ID: 19589079
    [Abstract] [Full Text] [Related]

  • 3. Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients.
    Vispo E, Cevik M, Rockstroh JK, Barreiro P, Nelson M, Scourfield A, Boesecke C, Wasmuth JC, Soriano V, European Network of Clinical Trials (NEAT).
    Clin Infect Dis; 2013 Apr 15; 56(8):1117-22. PubMed ID: 23315321
    [Abstract] [Full Text] [Related]

  • 4. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.
    Mendizabal M, Craviotto S, Chen T, Silva MO, Reddy KR.
    Ann Hepatol; 2009 Apr 15; 8(4):390-5. PubMed ID: 20009143
    [Abstract] [Full Text] [Related]

  • 5. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.
    Schiano TD, Kotler DP, Ferran E, Fiel MI.
    Am J Gastroenterol; 2007 Nov 15; 102(11):2536-40. PubMed ID: 17640321
    [Abstract] [Full Text] [Related]

  • 6. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients.
    Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, Pol S.
    AIDS; 2007 Jan 11; 21(2):187-92. PubMed ID: 17197809
    [Abstract] [Full Text] [Related]

  • 7. Non-cirrhotic portal hypertension in HIV-infected individuals.
    Scourfield A, Waters L, Holmes P, Panos G, Randell P, Jackson A, Mandalia S, Gazzard B, Nelson M.
    Int J STD AIDS; 2011 Jun 11; 22(6):324-8. PubMed ID: 21680667
    [Abstract] [Full Text] [Related]

  • 8. Noncirrhotic portal hypertension in HIV infection.
    Vispo E, Morello J, Rodriguez-Novoa S, Soriano V.
    Curr Opin Infect Dis; 2011 Feb 11; 24(1):12-8. PubMed ID: 21157331
    [Abstract] [Full Text] [Related]

  • 9. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Rey D, Hoen B, Chavanet P, Schmitt MP, Hoizey G, Meyer P, Peytavin G, Spire B, Allavena C, Diemer M, May T, Schmit JL, Duong M, Calvez V, Lang JM.
    J Antimicrob Chemother; 2009 Feb 11; 63(2):380-8. PubMed ID: 19036752
    [Abstract] [Full Text] [Related]

  • 10. Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm.
    Parikh ND, Martel-Laferriere V, Kushner T, Childs K, Vachon ML, Dronamraju D, Taylor C, Fiel MI, Schiano T, Nelson M, Agarwal K, Dieterich DT.
    J Infect Dis; 2014 Mar 01; 209(5):734-8. PubMed ID: 23911709
    [Abstract] [Full Text] [Related]

  • 11. Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature.
    Cesari M, Schiavini M, Marchetti G, Caramma I, Ortu M, Franzetti F, Galli M, Antinori S, Milazzo L.
    AIDS Patient Care STDS; 2010 Nov 01; 24(11):697-703. PubMed ID: 20969464
    [Abstract] [Full Text] [Related]

  • 12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2009 Apr 01; 27(4):222-35. PubMed ID: 19246124
    [Abstract] [Full Text] [Related]

  • 13. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR, Swiss HIV Cohort Study.
    Clin Infect Dis; 2008 Oct 15; 47(8):1093-101. PubMed ID: 18783328
    [Abstract] [Full Text] [Related]

  • 14. [Non-cirrhotic portal hypertension due to didanosina. A rare case].
    Gamero MT, Gallardo MS, Aguilar V, Bravo E, Guevara J, Mejia F.
    Rev Gastroenterol Peru; 2017 Oct 15; 37(1):87-90. PubMed ID: 28489843
    [Abstract] [Full Text] [Related]

  • 15. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.
    Antivir Ther; 2009 Oct 15; 14(3):339-47. PubMed ID: 19474468
    [Abstract] [Full Text] [Related]

  • 16. A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection.
    Yajima K, Uehira T, Otera H, Koizumi Y, Watanabe D, Kodama Y, Kuzushita N, Nishida Y, Mita E, Mano M, Shirasaka T.
    J Infect Chemother; 2014 Sep 15; 20(9):582-5. PubMed ID: 25034388
    [Abstract] [Full Text] [Related]

  • 17. Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.
    Chang HM, Tsai HC, Lee SS, Wann SR, Chen YS.
    Jpn J Infect Dis; 2012 Sep 15; 65(1):61-5. PubMed ID: 22274160
    [Abstract] [Full Text] [Related]

  • 18. Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'.
    Garvey LJ, Thomson EC, Lloyd J, Cooke GS, Goldin RD, Main J.
    AIDS; 2007 Jul 11; 21(11):1494-5. PubMed ID: 17589202
    [No Abstract] [Full Text] [Related]

  • 19. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec 11; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 20. Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
    Vispo E, Maida I, Barreiro P, Moreno V, Soriano V.
    HIV Clin Trials; 2008 Dec 11; 9(6):440-4. PubMed ID: 19203910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.